The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: The peptide marker for the prognosis of cancer

Cancer Biomarkers

Volumn 10, Issue 3-4, 2011, Pages 125-134

  Gill, Kamaldeep ^a   Mohanti, Bidhu Kalyan ^a   Singh, Abhay Kumar ^a   Mishra, Biswajit ^a   Dey, Sharmistha ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

HNSCC; LL37; prognostic marker; radiation therapy

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURFACE PLASMON RESONANCE; TONGUE CARCINOMA; TONSIL CARCINOMA; TREATMENT RESPONSE;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CARCINOMA, SQUAMOUS CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84862855593     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-0238     Document Type: Article

References (37)

1. M. Zanetti, R. Gennaro and D. Romeo, Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain, FEBS Lett 374 (1995), 1-5.
2. O.E. Sorensen, P. Follin, A.H. Johnsen, J. Calafat, G.S. Tjabringa, P.S. Hiemstra and N. Borregaard, Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3, Blood 97 (2001), 3951-3959.
3. R.A. Dorschner, V.K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G.H. Gudmundsson and R.L. Gallo, Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus, J Invest Dermatol 117 (2001), 91-97. (Pubitemid 32652444)
4. M. Zasloff, Antimicrobial peptides of multicellular organisms, Nature 415 (2002), 389-395. (Pubitemid 34100944)
5. Z. Oren, J.C. Lerman, G.H. Gudmundsson, B. Agerberth and Y Shai, Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity, Biochem J 341 (1999), 501-513. (Pubitemid 29389178)
6. B. Ramanathan, E.G. Davis, C.R. Ross and F. Blecha, Cathelicidins: microbicidal activity, mechanism of action, and roles in innate immunity, Microbes Infect 4 (2002), 361-372. (Pubitemid 34293642)
7. R. Koczulla, G. von Degenfeld, C. Kupatt, F. Krotz, S. Zahler, T. Gloe, K. Issbrucker, P. Unterberger, M. Zaiou, C. Labherz, A. Karl, P. Rakke, A. Pfosser, P. Boekstegers, U. Welsch, P.S. Hiemstra, C. Vogelmeier, R.L. Gallo, M. Clauss and R. Bals, An angiogenic role for the human peptide antibiotic LL-37/hCAP-18, J Clin Invest 111 (2003). 1665-1672. (Pubitemid 38057748)
8. M.H. Braff, M.A. Hawkins, A. Di Nardo, B. Lopez-Garcia, M.D. Howell, C. Wong, K. Lin, J.E. Streib, R. Dorschner, D.Y. Leung and R.L. Gallo, Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities, J Immunol 174 (2005), 4271-4278. (Pubitemid 40396008)
9. R. Shaykhiev, C. Beisswenger, K. Kandler, J. Senske, A. Puchner, T. Damm, J. Behr and R. Bals, Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure, Am J Physiol Lung Cell Mol Physiol 289 (2005), 842-848.
10. M.D. Howell, J.F.J Jones, K.O. Kisich, J.E. Streib, R.L. Gallo and D.Y. Leung, Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum, J Immunol 172 (2004), 1763-1767. (Pubitemid 38116824)
11. B. Lopez-Garcia, P.H. Lee, K. Yamasaki and R.L. Gallo, Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection, J Invest Dermatol 125 (2005), 108-115. (Pubitemid 40981431)
12. R. Bals, X.Wang, M. Zasloff and J.M.Wilson, The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface, Proc Natl Acad Sci USA 95 (1998), 9541-9546. (Pubitemid 28506267)
13. D. Yang, Q. Chen, A.P. Schmidt, G.M. Anderson, J.M.Wang, J. Wooters, J.J. Oppenheim and O. Chertov, LL-37 the neutrophil granule and epithelial cell-derived cathelicidin, uses formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes and T cells, J ExpMed 192 (2000), 1069-1074.
14. G.S. Tjabringa, D.K. Ninaber, J.W. Drijfhout, K.F. Rabe and P.S. Hiemstra, Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that act via formyl-peptide receptors, Int Arch Allergy Immunol 140 (2006), 103-112. (Pubitemid 43725804)
15. F. Niyonsaba, K. Iwabuchi, A. Someya, M. Hirata, H. Matsuda, H. Ogawa and I. Nagaoka, A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis, Immunology 106 (2002), 20-26. (Pubitemid 34437873)
16. S.B. Coffelt, R.S.Waterman, L. Florez, K. Honer Zu Bentrup, K.J. Zwezdaryk, S.I. Tomchuck, H.L. LaMarca, E.S. Danka, C.A. Morris and A.B. Scandurro, Ovarian cancer overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion, Int J Cancer 122 (2008), 1030-1039. (Pubitemid 351214000)
17. J.D. Heilborn, M.F. Nilsson, C.I. Jimenez, B. Sandstedt, N. Borregaard, E. Tham, O.E. Sorensen, G. Weber and M. Stahle, Antimicrobial protein hCAP18/LL37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells, Int J Cancer 114 (2005), 713-719. (Pubitemid 40344432)
18. J. von Haussen, R. Koczulla, R. Shaykhiew, C. Herr, O. Pinkenburg, D. Reimer, R.Wiewrodt, S. Biesterfeld, A. Aigner, F. Czubayko and R. Bals, The host defense peptide LL37 is a growth factor for lung cancer cells, Lung Cancer 59 (2008), 12-23.
19. W.K.K. Wu, G. Wang, S.B. Coffeelt, A.M. Betancourt, C.W. Lee, D. Fan, K.Wu, J.Yu, J.J.Y. Sung and C.H. Cho, Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications, Int J Cancer 127 (2010), 1741-1747.
20. A. Otto, Excitation of nonradiative surface plasma waves in silver by the method of frustrated total reflection, Z Phys 216 (1968), 398-410.
21. E. Kretschmann and H. Reather, Radiative decay of nonradiative surface Pasmon excited by light, Natur 23A (1968), 2135-2136.
22. C. Nylander, B. Leidberg and T. Lind. Gas detection by means of surface Plasmon resonance, Sens Actuators 3 (1982), 79-88. (Pubitemid 13459131)
23. J. Johansson, G.H. Gudmundsson, M.E. Rottenberg, K.D. Berndt and B. Agerberth, Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37, J Biol Chem 273 (1998), 3718-3124.
24. H. Schroder-Borm, R. Bakalova and J. Andra, The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine, FEBS Lett 579 (2005), 6128-6134. (Pubitemid 41546259)
25. W.K. Wu, J.J. Sung, K.F. To, L. Yu, H.T. Li, Z.J. Li, K.M. Chu, J. Yu and C.H. Cho, The host defense peptide LL37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells, J Cell Physiol 223 (2010), 178-186.
26. G.Wang, X. Li and Z.Wang, APD2: the updated antimicrobial peptide database and its application in peptide design, Nucleic Acid Res 37 (2009), 933-937.
27. X. Li, Y. Li, H. Han, D.W. Miller and G. Wang, Solution structures of human LL-37 fragments and NMR-based identification of minimal membrane targeting antimicrobial and anticancer region, J Am Chem Soc 128 (2006), 5776-5785. (Pubitemid 43724381)
28. J.S. Mader and D.W. Hoskin, Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment, Expert Opin Invest Drugs 15 (2008), 933-946.
29. G. Wang, NMR of membrane-associated peptides and proteins, Curr Protein Pept Sci 9 (2008), 50-69.
30. Y. Li, X. Li and G. Wang, Cloning, expression, isotope labeling and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies, Protein, Expr Purif 47 (2006), 498-505. (Pubitemid 43744452)
31. G.Wang, Structure of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles, J Biol Chem 283 (2008), 32637-32643.
32. G.Wang, Determination of solution structure and lipid micelle location aof an engineered membrane peptide by using one NMR experiment and one sample, Biochim Biophy Acta 1768 (2007), 3271-3281.
33. R.F. Epand, G.Wang, B. Berno and R.M. Epand, Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37, Antimicrob Agents Chemother 53 (2009), 3705-3714.
34. D. Yang, Q. Chen, A.P. Schmidt, G.M. Anderson, J.M.Wang, J. Wooters, J.J. Oppenheim and O. Chertov, LL-37, the neutrophil granule and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes and T cells, J ExpMed 192 (2000), 1069-1074.
35. S.B. Coffelt, S.I. Tomchuck, K.J. Zwezdaryk, E.S. Danka and A.B. Scandurro, Leucine leucine-37 uses formyl peptide receptor-like 1 to active signal transduction pathways, stimulate oncogenic gene expression and enhance the invasiveness of ovarian cancer cells, Mol Cancer Res 7 (2009), 907-915.
36. K. Hase, M. Muraskami, M. Limura, S.P. Cole, Y. Horibe, T. Ohtake, M. Obonyo, R.L. Gallo, L. Eckmann and M.F. Kagnoff, Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori, Gastroenterology 125 (2003), 1613-1625. (Pubitemid 37500425)
37. I.H. Chen, J.T. Chang, C.T. Liao, H.M. Wang, L.L. Hsieh and A.J. Cheng, Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area, British J Cancer 89 (2003), 681-686. (Pubitemid 37076173)